Work

TG101209, a small molecule JAK2-selective kinase inhibitor potently inhibits myeloproliferative disorder-associated JAK2V617F and MPLW515L/K mutations

Year: 2007

Type: article

Source: Leukemia

DOI: 10.1038/sj.leu.2404750

Authors: A Pardanani, J Hood, T Lasho, R L Levine, M B Martin, G Noronha, C Finke, C C Mak, R Mesa, H Zhu, R Soll, D G Gilliland, A Tefferi

Institutions: Mayo Clinic, Brigham and Women's Hospital, Harvard University, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Howard Hughes Medical Institute

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Mayo Clinic

OpenAlex ID: W2135699328

FWCI: 16.22

Cites: 23

Cited by: 272

Related to: 10